Strategies to Block HIV Transcription: Focus on Small Molecule Tat Inhibitors

Por Mousseau, Guillaume, Valente, Susana
Publicado em 2012

Didehydro-Cortistatin A: a new player in HIV-therapy?

Por Mousseau, Guillaume, Valente, Susana T.
Publicado no Expert Rev Anti Infect Ther (2015)

Role of Host Factors on the Regulation of Tat-Mediated HIV-1 Transcription

Por Mousseau, Guillaume, Valente, Susana T.
Publicado no Curr Pharm Des (2017)

Key Players in HIV-1 Transcriptional Regulation: Targets for a Functional Cure

Por Mori, Luisa, Valente, Susana T.
Publicado no Viruses (2020)

Block-And-Lock: New Horizons for a Cure for HIV-1

Por Moranguinho, Ines, Valente, Susana T.
Publicado no Viruses (2020)

SOMATIC CELL GENETIC ANALYSES TO IDENTIFY HIV-1 HOST RESTRICTION FACTORS

Por Valente, Susana T., Goff, Stephen P.
Publicado em 2009

HIV-1 capsid inhibitors as antiretroviral agents

Por Thenin-Houssier, Suzie, Valente, Susana T.
Publicado no Curr HIV Res (2016)

Targeting HIV Transcription: The Quest for a Functional Cure

Por Mousseau, Guillaume, Mediouni, Sonia, Valente, Susana T.
Publicado no Curr Top Microbiol Immunol (2015)

Tat inhibition by didehydro-Cortistatin A promotes heterochromatin formation at the HIV-1 long terminal repeat

Por Li, Chuan, Mousseau, Guillaume, Valente, Susana T.
Publicado no Epigenetics Chromatin (2019)

The Block-and-Lock Strategy for Human Immunodeficiency Virus Cure: Lessons Learned from Didehydro–Cortistatin A

Por Li, Chuan, Mori, Luisa, Valente, Susana T
Publicado no J Infect Dis (2021)

No evidence for prolactin’s involvement in the post-ejaculatory refractory period

Por Valente, Susana, Marques, Tiago, Lima, Susana Q.
Publicado no Commun Biol (2021)

Analysis of RNA Processing Reactions Using Cell Free Systems: 3' End Cleavage of Pre-mRNA Substrates in vitro

Por Jablonski, Joseph, Clementz, Mark, Ryan, Kevin, Valente, Susana T.
Publicado em 2014

Cell Permeable Peptides Containing “Cycloalanine” Residues

Por Wu, Hao, Mousseau, Guillaume, Mediouni, Sonia, Valente, Susana T., Kodadek, Thomas
Publicado no Angew Chem Int Ed Engl (2016)

Inhibition of HIV-1 replication by eIF3f

Por Valente, Susana T., Gilmartin, Greg M., Mott, Christina, Falkard, Brie, Goff, Stephen P.
Publicado em 2009

HIV-1 mRNA 3’ end processing is distinctively regulated by eIF3f, CDK11, and splice factor 9G8

Por Valente, Susana T., Gilmartin, Greg M., Venkatarama, Krishnan, Arriagada, Gloria, Goff, Stephen P.
Publicado em 2009

The Tat Inhibitor Didehydro-Cortistatin A Prevents HIV-1 Reactivation from Latency

Por Mousseau, Guillaume, Kessing, Cari F., Fromentin, Rémi, Trautmann, Lydie, Chomont, Nicolas, Valente, Susana T.
Publicado no mBio (2015)

CXCR4 Is Down-Regulated in Cells Infected with the CD4-Independent X4 Human Immunodeficiency Virus Type 1 Isolate m7NDK

Por Valente, Susana T., Chanel, Chantal, Dumonceaux, Julie, Olivier, René, Marullo, Stephano, Briand, Pascale, Hazan, Uriel
Publicado em 2001

The cross-talk of HIV-1 Tat and methamphetamine in HIV-associated neurocognitive disorders

Por Mediouni, Sonia, Garibaldi Marcondes, Maria Cecilia, Miller, Courtney, McLaughlin, Jay P., Valente, Susana T.
Publicado no Front Microbiol (2015)

Didehydro-Cortistatin A inhibits HIV-1 Tat mediated neuroinflammation and prevents potentiation of cocaine reward in Tat transgenic mice

Por Mediouni, Sonia, Jablonski, Joseph, Paris, Jason J., Clementz, Mark A., Thenin-Houssier, Suzie, McLaughlin, Jay P., Valente, Susana T.
Publicado no Curr HIV Res (2015)

Moesin regulates stable microtubule formation and limits retroviral infection in cultured cells

Por Naghavi, Mojgan H, Valente, Susana, Hatziioannou, Theodora, de los Santos, Kenia, Wen, Ying, Mott, Christina, Gundersen, Gregg G, Goff, Stephen P
Publicado em 2007